User:Mr. Ibrahem/Vorapaxar

Vorapaxar, sold under the brand name Zontivity, is a medication used to decrease the risk of heart attacks and stroke in those with atherosclerosis. Overall benefits; however, remain unclear as of 2021. It is taken by mouth.

Common side effects include bleeding, which may include intracranial bleeding. It is a thrombin receptor (protease-activated receptor, PAR-1) blocker based on the natural product himbacine. It works by blocking platelet aggregation.

Vorapaxar was approved for medical use in the United States in 2014. While it was approved for use in Europe in 2015, this approval was withdrawn in 2017. In the United States it costs about 370 USD per month as of 2021.